Alterity Therapeutics (ATHE) Short Interest Ratio & Short Volume $1.07 +0.02 (+1.90%) (As of 11:27 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends Alterity Therapeutics Short Interest DataAlterity Therapeutics (ATHE) has a short interest of 3,600 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a -41.94% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 43,701 shares to cover all short positions.Current Short Interest3,600 sharesPrevious Short Interest6,200 sharesChange Vs. Previous Month-41.94%Dollar Volume Sold Short$4,140.00Short Interest Ratio0.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares7,300,000 sharesFloat Size8,450,000 sharesShort Percent of Float0.04%Today's Trading Volume4,401 sharesAverage Trading Volume43,701 sharesToday's Volume Vs. Average10% Short Selling Alterity Therapeutics? Sign up to receive the latest short interest report for Alterity Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATHE Short Interest Over TimeATHE Days to Cover Over TimeATHE Percentage of Float Shorted Over Time Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Alterity Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20243,600 shares $4,140.00 -41.9%0.0%0.3 $1.15 10/15/20246,200 shares $7,810.14 -36.1%0.1%0.4 $1.26 9/30/20249,700 shares $12,731.25 -22.4%0.1%0.3 $1.31 9/15/202412,500 shares $15,750.00 -40.5%0.2%0.4 $1.26 8/31/202421,000 shares $31,290.00 -8.7%0.3%0.6 $1.49 8/15/202423,000 shares $31,740.00 -18.2%0.3%0.7 $1.38 Get the Latest News and Ratings for ATHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202428,100 shares $44,957.19 +57.0%0.3%0.8 $1.60 7/15/202417,900 shares $35,979.00 +33.6%0.2%0.4 $2.01 6/30/202413,400 shares $24,254.00 -40.4%0.2%0.2 $1.81 6/15/202422,500 shares $41,850.00 +8.2%0.3%0.3 $1.86 5/31/202420,800 shares $38,896.00 -40.6%0.3%0.3 $1.87 5/15/202435,000 shares $71,400.00 -59.3%0.4%0.4 $2.04 4/30/202485,900 shares $179,960.50 -4.9%1.0%1.1 $2.10 4/15/202490,300 shares $221,235.00 +290.9%1.1%1.1 $2.45 3/31/202423,100 shares $47,817.00 -12.5%0.3%0.6 $2.07 3/15/202426,400 shares $46,464.00 +47.5%0.3%0.6 $1.76 2/29/202417,900 shares $33,473.00 -52.7%0.2%0.3 $1.87 2/15/202437,800 shares $76,356.00 +25.6%0.5%0.1 $2.02 1/31/202430,100 shares $63,511.00 +85.8%N/A0 $2.11 1/15/202416,200 shares $30,780.00 -77.0%0.3%0 $1.90 12/31/202370,500 shares $175,545.00 +22.8%1.2%0.1 $2.49 12/15/202357,400 shares $173,922.00 +12.6%1.3%0.1 $3.03 11/30/202351,000 shares $92,310.00 +684.6%1.2%0.1 $1.81 11/15/20236,500 shares $15,925.00 -11.0%0.2%1.2 $2.45 10/31/20237,300 shares $17,022.14 -32.4%0.2%2.6 $2.33 10/15/202310,800 shares $26,244.00 -12.9%0.3%3.4 $2.43 9/30/202312,400 shares $30,752.00 -13.3%0.3%3.2 $2.48 9/15/202314,300 shares $37,180.00 -14.4%0.4%3.6 $2.60 8/31/202316,700 shares $45,257.00 -13.0%0.4%3.9 $2.71 8/15/202319,200 shares $54,528.00 +12.9%0.5%4 $2.84 7/31/202317,000 shares $49,300.00 +54.6%0.4%3.7 $2.90 7/15/202311,000 shares $31,128.90 +15.8%0.3%2.3 $2.83 6/30/20239,500 shares $26,505.00 -41.7%0.2%2.2 $2.79 6/15/202316,300 shares $47,107.00 +6.5%0.4%2.3 $2.89 5/31/202315,300 shares $44,523.00 +1.3%0.4%0.9 $2.91 5/15/202315,100 shares $43,790.00 +0.7%0.4%0.9 $2.90 4/30/202315,000 shares $41,998.50 -35.3%0.4%0.7 $2.80 4/15/202323,200 shares $66,816.00 -27.3%0.6%1 $2.88 3/31/202331,900 shares $88,682.00 +423.0%0.8%1.1 $2.78 3/15/20236,100 shares $15,921.00 -14.1%0.2%0.2 $2.61Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 2/28/20237,100 shares $22,791.00 +6.0%0.2%0.4 $3.21 2/15/20236,700 shares $20,167.00 -22.1%0.2%0.4 $3.01 1/31/20238,600 shares $33,626.00 -34.4%0.2%0.5 $3.91 1/15/202313,100 shares $54,365.00 +10.1%0.3%1 $4.15 12/30/202211,900 shares $41,435.80 -90.5%N/A1.1 $3.48 12/15/2022125,500 shares $40,172.55 -3.9%N/A2.2 $0.32 11/30/2022130,600 shares $47,329.44 -15.3%N/A1.5 $0.36 11/15/2022154,100 shares $61,640.00 -33.1%N/A1.6 $0.40 10/31/2022230,200 shares $90,445.58 -6.9%N/A2.3 $0.39 10/15/2022247,200 shares $113,687.28 -2.4%N/A2.3 $0.46 9/30/2022253,200 shares $111,433.32 -4.3%N/A2.3 $0.44 9/15/2022264,700 shares $153,472.80 +22.5%N/A2.3 $0.58 8/31/2022216,100 shares $121,037.61 +27.5%N/A2.5 $0.56 8/15/2022169,500 shares $105,123.90 -34.9%N/A2.3 $0.62 7/31/2022260,300 shares $156,960.90 +0.4%N/A3.5 $0.60 7/15/2022259,300 shares $163,359.00 +9.7%N/A2.8 $0.63 6/30/2022236,400 shares $144,440.40 +36.5%N/A2.8 $0.61 6/15/2022173,200 shares $107,418.64 -30.2%N/A2 $0.62 5/31/2022248,000 shares $166,160.00 -13.9%N/A2.8 $0.67 5/15/2022287,900 shares $190,762.54 -25.4%N/A2.7 $0.66 4/30/2022385,700 shares $284,299.47 +63.5%N/A2.9 $0.74 4/15/2022235,900 shares $184,002.00 -7.6%N/A1.8 $0.78 3/31/2022255,200 shares $211,560.80 +13.8%N/A0.1 $0.83 3/15/2022224,200 shares $159,742.50 -37.9%N/A0.1 $0.71 2/28/2022360,800 shares $306,680.00 -22.9%N/A0.2 $0.85 2/15/2022467,900 shares $427,660.60 -24.4%N/A0.2 $0.91 1/31/2022619,200 shares $582,233.76 -44.7%N/A0.3 $0.94 1/15/20221,120,000 shares $909,216.00 +231.1%N/A0.4 $0.81 12/31/2021338,300 shares $243,576.00 -16.6%N/A0.1 $0.72 12/15/2021405,600 shares $349,627.20 -32.1%N/A1 $0.86 11/30/2021597,000 shares $579,090.00 -2.4%N/A1.3 $0.97 11/15/2021611,900 shares $712,496.36 -25.9%N/A1.3 $1.16 10/29/2021826,100 shares $1.01 million +19.1%N/A1.6 $1.22 10/15/2021693,500 shares $908,485.00 -6.4%N/A0.5 $1.31 9/30/2021740,700 shares $940,689.00 -13.0%N/A0.4 $1.27 9/15/2021851,600 shares $1.10 million +1.1%N/A0.1 $1.29 8/31/2021842,100 shares $1.15 million -11.4%N/A0.1 $1.36 8/13/2021950,600 shares $1.28 million -8.6%N/A0.1 $1.35 7/30/20211,040,000 shares $1.34 million -9.6%N/A0.2 $1.29 7/15/20211,150,000 shares $1.73 million +108.0%N/A0.2 $1.50 6/30/2021552,800 shares $718,640.00 -13.4%N/A0.1 $1.30 6/15/2021638,400 shares $874,608.00 +9.6%N/A0.4 $1.37 5/28/2021582,300 shares $780,282.00 -9.3%N/A0.4 $1.34 5/14/2021642,200 shares $732,108.00 -28.3%N/A0.4 $1.14 4/30/2021895,500 shares $1.33 million +304.1%N/A0.5 $1.49 4/15/2021221,600 shares $292,512.00 +31.0%N/A0.1 $1.32 3/31/2021169,200 shares $240,264.00 +18.0%N/A0.3 $1.42 3/15/2021143,400 shares $246,648.00 +412.1%N/A0.2 $1.72 2/26/202128,000 shares $47,320.00 -71.6%N/A0 $1.69 2/12/202198,700 shares $203,322.00 +961.3%N/A0.1 $2.06Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide 1/29/20219,300 shares $15,717.00 -90.6%N/A0 $1.69 1/15/202199,200 shares $174,592.00 +91.1%N/A0 $1.76 12/31/202051,900 shares $72,660.00 -10.1%N/A0 $1.40 12/15/202057,700 shares $86,550.00 -84.0%N/A0 $1.50 11/30/2020360,800 shares $559,240.00 +574.4%N/A0.2 $1.55 11/15/202053,500 shares $61,525.00 +29.5%N/A0 $1.15 10/30/202041,300 shares $56,994.00 +1,232.3%N/A0.4 $1.38 10/15/20203,100 shares $6,293.00 -40.4%N/A0 $2.03 9/30/20205,200 shares $10,504.00 -82.7%N/A0 $2.02 9/15/202030,000 shares $62,100.00 -86.2%N/A0 $2.07 ATHE Short Interest - Frequently Asked Questions What is Alterity Therapeutics' current short interest? Short interest is the volume of Alterity Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 3,600 shares of ATHE short. 0.04% of Alterity Therapeutics' shares are currently sold short. Learn More on Alterity Therapeutics' current short interest. What is a good short interest percentage for Alterity Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Alterity Therapeutics' floating shares are currently sold short. Is Alterity Therapeutics' short interest increasing or decreasing? Alterity Therapeutics saw a decline in short interest in October. As of October 31st, there was short interest totaling 3,600 shares, a decline of 41.9% from the previous total of 6,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alterity Therapeutics' float size? Alterity Therapeutics currently has issued a total of 7,300,000 shares. Some of Alterity Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alterity Therapeutics currently has a public float of 8,450,000 shares. How does Alterity Therapeutics' short interest compare to its competitors? 0.04% of Alterity Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Alterity Therapeutics: Lantern Pharma Inc. (2.06%), Janone Inc. (1.13%), Surrozen, Inc. (1.47%), Citius Pharmaceuticals, Inc. (6.52%), HCW Biologics Inc. (0.04%), BioVie Inc. (35.04%), RenovoRx, Inc. (0.31%), KALA BIO, Inc. (1.02%), BioLineRx Ltd. (1.33%), Daré Bioscience, Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Alterity Therapeutics stock? Short selling ATHE is an investing strategy that aims to generate trading profit from Alterity Therapeutics as its price is falling. ATHE shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alterity Therapeutics? A short squeeze for Alterity Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATHE, which in turn drives the price of the stock up even further. How often is Alterity Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATHE, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Lantern Pharma Short Interest Data Janone Short Interest Data Surrozen Short Interest Data Citius Pharmaceuticals Short Interest Data HCW Biologics Short Interest Data BioVie Short Interest Data RenovoRx Short Interest Data KALA BIO Short Interest Data BioLineRx Short Interest Data Daré Bioscience Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATHE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHE Stock Alerts